Innovative Eyewear Stock (NASDAQ:LUCY)


RevenueOwnershipFinancialsChart

Previous Close

$0.79

52W Range

$0.66 - $2.39

50D Avg

$0.94

200D Avg

$1.30

Market Cap

$3.03M

Avg Vol (3M)

$78.13K

Beta

2.70

Div Yield

-

LUCY Company Profile


Innovative Eyewear, Inc. specializes in the design and commercialization of intelligent eyewear, encompassing both eyeglasses and sunglasses. Central to its product line is Lucyd Lyte, a pair of smart glasses empowering users to engage with audio content, manage phone conversations, and activate smartphone functions hands-free through voice commands. Additionally, the company provides Vyrb, a social media application facilitating the vocal exchange of posts directly through Lucyd Lyte smart glasses. Its offerings reach consumers via diverse e-commerce platforms and traditional retail outlets. Established in 2019 and headquartered in North Miami, Florida, Innovative Eyewear, Inc. operates as a subsidiary of Lucyd Ltd., reflecting its close collaboration with the latter.

Show More

Industry

Medical - Instruments & Supplies

Sector

Healthcare

Exchange

NASDAQ

ADR

-

Country

US

Employees

11

IPO Date

Aug 15, 2022

Website

LUCY Performance


Revenue Breakdown


Revenue Breakdown by Product/Service

Product/ServiceMar 26Sep 25Jun 25Mar 25
Subscriptions$1.80K$325.00$908.00$1.03K

Fiscal year ends in Dec 25 | Currency in USD

LUCY Financial Summary


Dec 25Dec 24Dec 23
Revenue$2.66B$1.64M$1.15M
Operating Income$-2.41B$-7.92M$-6.86M
Net Income$-7.59B$-7.77M$-6.66M
EBITDA$-2.41B$-7.62M$-6.58M
Basic EPS-$-5.19$-12.67
Diluted EPS-$-5.19$-12.67

Fiscal year ends in Dec 25 | Currency in USD

Peer Comparison


TickerCompany
POAIPredictive Oncology Inc.
PFSAProfusa, Inc. Common Stock
CELZCreative Medical Technology Holdings, Inc.
SBFMSunshine Biopharma, Inc.
MHUAMeihua International Medical Technologies Co., Ltd.
BMRABiomerica, Inc.
KPRXKiora Pharmaceuticals, Inc.
APREAprea Therapeutics, Inc.
BCDABioCardia, Inc.